← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 31, 2019Last known activity
Jul 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07257874Lead sponsorPhase 3Jul 1, 2025
- NCT06856369CollaboratorPhase 4Jan 22, 2025
- NCT06243601Lead sponsorPhase 1Nov 30, 2023
- NCT06125873Lead sponsorPhase 2Mar 15, 2023
- NCT06125873Reponsible party - principal investigatorPhase 2Mar 15, 2023
- NCT06125873Sponsor investigatorPhase 2Mar 15, 2023
- NCT04724187Lead sponsorPhase 2Feb 3, 2021
- NCT04724187Reponsible party - principal investigatorPhase 2Feb 3, 2021
- NCT04604366Lead sponsorPhase 2Nov 30, 2020
- NCT04604366Reponsible party - principal investigatorPhase 2Nov 30, 2020
- NCT03982849Reponsible party - principal investigatorPhase 2Jul 31, 2019
- NCT03982849Overall official - principal investigatorPhase 2Jul 31, 2019
- NCT03982849Lead sponsorPhase 2Jul 31, 2019
Details
- Last known activity
- Jul 1, 2025